CoreValve, S.A. Reports New Milestone In ReValving(TM) Procedures

IRVINE, Calif.--(BUSINESS WIRE)--July 12, 2006--"With our imminent transition to an 18-French system and the anticipated continued use of temporary percutaneous left ventricular assist devices for unloading the heart, our entire ReValving procedure can now be a truly percutaneous alternative to open-heart surgery for replacing a diseased aortic heart valve.”

MORE ON THIS TOPIC